Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial.

The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare c...

Full description

Bibliographic Details
Published in:European Heart Journal - Quality of Care and Clinical Outcomes
Main Authors: Aarts, Goaris W A, Camaro, Cyril, Adang, Eddy M M, Rodwell, Laura, van Hout, Roger, Brok, Gijs, Hoare, Anouk, de Pooter, Frank, de Wit, Walter, Cramer, Gilbert E, van Kimmenade, Roland R J, Ouwendijk, Eva, Rutten, Martijn H, Zegers, Erwin, van Geuns, Robert-Jan M, Gomes, Marc E R, Damman, Peter, van Royen, Niels
Format: Article in Journal/Newspaper
Language:English
Published: Silverchair Information Systems 2024
Subjects:
Acute coronary syndrome
Ambulance
Cost-effectiveness
Healthcare economics
Point-of-care troponin
Mace
artica
Online Access:https://doi.org/10.1093/ehjqcco/qcae004
https://pubmed.ncbi.nlm.nih.gov/38236708
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307197/
Description
Summary:The healthcare burden of acute chest pain is enormous. In the randomized ARTICA trial, we showed that pre-hospital identification of low-risk patients and rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) with point-of-care (POC) troponin measurement reduces 30-day healthcare costs with low major adverse cardiac events (MACE) incidence. Here we present the final 1-year results of the ARTICA trial.

Similar Items